Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Risk Factors
100%
AIDS/HIV
100%
Zidovudine
100%
Virus Transmission
100%
Human Immunodeficiency Virus Type 1 (HIV-1)
50%
Treatment Effect
37%
Relative Reduction
37%
Maternal Blood
25%
Chemoprophylaxis
25%
Fetal Exposure
25%
Interaction Test
25%
Cervical mucus
25%
Maternal Weight
25%
Transmission Risk
25%
Intrapartum Risk Factors
25%
Multivariate Analysis
12%
Placebo
12%
CD4+
12%
MRNA Level
12%
With Woman
12%
Treatment Group
12%
Univariate Analysis
12%
Maternal Condition
12%
AIDS Clinical Trials
12%
Antepartum
12%
Placebo-controlled Trial
12%
Differential Treatment Effects
12%
Group Communication Protocol
12%
Univariate Statistical Analysis
12%
Multivariate Statistical Analysis
12%
Pediatric AIDS
12%
Obstetric Factors
12%
Cell Percentage
12%
Heavyweight
12%
Medicine and Dentistry
Human Immunodeficiency Virus
100%
Zidovudine
100%
Virus Transmission
100%
Human Immunodeficiency Virus 1
50%
Treatment Effect
50%
Placebo
25%
Secretion (Process)
25%
Chemoprophylaxis
25%
Maternal Blood
25%
Multivariate Analysis
25%
Acquired Immune Deficiency Syndrome
12%
Clinical Trial
12%
Pediatrics
12%
Obstetrics
12%
Intrapartum
12%
Univariate Analysis
12%
Treatment Group
12%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Zidovudine
100%
Virus Transmission
100%
Human Immunodeficiency Virus 1
50%
Placebo
25%
Chemoprophylaxis
25%
Acquired Immune Deficiency Syndrome
12%
Clinical Trial
12%
Treatment Group
12%